These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17895751)

  • 1. Microsatellite and EGFR, HER2 and K-RAS analyses in sclerosing hemangioma of the lung.
    Sartori G; Bettelli S; Schirosi L; Bigiani N; Maiorana A; Cavazza A; Rossi G
    Am J Surg Pathol; 2007 Oct; 31(10):1512-20. PubMed ID: 17895751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of genetic and epigenetic alterations at 11 tumor suppressor loci in pulmonary sclerosing hemangioma and adenocarcinoma.
    Lee HJ; Jang SJ; Chun SM; Park SI; Kim DK; Choi J
    Exp Lung Res; 2011 Aug; 37(6):344-53. PubMed ID: 21649526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral genetic heterogeneity in Barrett adenocarcinoma.
    Owonikoko T; Rees M; Gabbert HE; Sarbia M
    Am J Clin Pathol; 2002 Apr; 117(4):558-66. PubMed ID: 11939730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcomatoid carcinoma of the upper urinary tract: clinical outcome and molecular characterization.
    Wang X; MacLennan GT; Zhang S; Montironi R; Lopez-Beltran A; Tan PH; Foster S; Baldridge LA; Cheng L
    Hum Pathol; 2009 Feb; 40(2):211-7. PubMed ID: 18799188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene amplification of ERBB2 and EGFR in adenocarcinoma in situ and intramucosal adenocarcinoma of Barrett's esophagus.
    Ooi A; Zen Y; Ninomiya I; Tajiri R; Suzuki S; Kobayashi H; Imoto I; Dobashi Y
    Pathol Int; 2010 Jun; 60(6):466-71. PubMed ID: 20518902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 protein expression and genetic mutation in two primary cell types in pulmonary sclerosing haemangioma.
    Wang Y; Dai SD; Qi FJ; Xu HT; Wang EH
    J Clin Pathol; 2008 Feb; 61(2):192-6. PubMed ID: 17704262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors.
    Lantuejoul S; Nicholson AG; Sartori G; Piolat C; Danel C; Brabencova E; Goldstraw P; Brambilla E; Rossi G
    Am J Surg Pathol; 2007 Jun; 31(6):961-9. PubMed ID: 17527088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus.
    Walker F; Abramowitz L; Benabderrahmane D; Duval X; Descatoire V; Hénin D; Lehy T; Aparicio T
    Hum Pathol; 2009 Nov; 40(11):1517-27. PubMed ID: 19716155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic mucinous cystic neoplasms with sarcomatous stroma: molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components.
    van den Berg W; Tascilar M; Offerhaus GJ; Albores-Saavedra J; Wenig BM; Hruban RH; Gabrielson E
    Mod Pathol; 2000 Jan; 13(1):86-91. PubMed ID: 10658914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.
    Sartori G; Cavazza A; Sgambato A; Marchioni A; Barbieri F; Longo L; Bavieri M; Murer B; Meschiari E; Tamberi S; Cadioli A; Luppi F; Migaldi M; Rossi G
    Am J Clin Pathol; 2009 Apr; 131(4):478-89. PubMed ID: 19289583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
    Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
    Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Awaya H; Takeshima Y; Furonaka O; Kohno N; Inai K
    J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features.
    El-Zammar OA; Zhang S; Katzenstein AL
    Diagn Mol Pathol; 2009 Sep; 18(3):133-7. PubMed ID: 19704257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.
    Dacic S; Sasatomi E; Swalsky PA; Kim DW; Finkelstein SD; Yousem SA
    Arch Pathol Lab Med; 2004 Aug; 128(8):880-4. PubMed ID: 15270615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung.
    Kim YT; Kim TY; Lee DS; Park SJ; Park JY; Seo SJ; Choi HS; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
    Lung Cancer; 2008 Jan; 59(1):111-8. PubMed ID: 17904685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.